Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-05-06 00:00:00 ET · period of report 2025-05-02 · accession 0001127602-25-013478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-06 | 2025-05-02 | BCRX | Frank Steven | Dir | A - Grant | $0.00 | +1,866 | 1,866 | New | $0 |
| D | 2025-05-06 | 2025-05-02 | BCRX | Frank Steven | Dir | A - Grant | $0.00 | +4,079 | 4,079 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | A | A | 1,866 | $0.00 | 1,866 | D | — | — | (F1) Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest in three equal annual installments beginning on the twelve-month anniversary of the date of grant. |
| 2 | Derivative | Automatic Stock Option Grant | 2025-05-02 | A | A | 4,079 | $0.00 | 4,079 | D | $8.93 · — to 2035-05-02 | 4,079 Common Stock | (F2) Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy. (F3) The option grant vests 1/36 per month over a 3-year period measured from the date of grant. |